外泌体诊断和治疗市场按类型、产品/服务、来源、应用、最终用户和地区划分

2025 年全球外泌体诊断和治疗市场规模估计为 9,280 万美元，预计到 2032 年将达到 3.084 亿美元，2025 年至 2032 年的复合年增长率为 18.7%。

数字。外泌体诊断和治疗市场份额（按地区划分）（2025年）

近年来，全球外泌体诊断和治疗市场显着成长。外泌体是奈米大小的细胞外囊泡，可作为蛋白质、脂质和核酸等生物分子的载体。它在细胞间通讯和免疫反应中发挥重要作用。外泌体在癌症、神经系统疾病和心血管疾病等各种疾病的诊断和治疗中的应用日益广泛，正在推动该市场的成长。研发和医疗保健产业参与者越来越多地挖掘外泌体的潜力，以开发微创液态切片、药物输送解决方案和再生疗法。分离和表征技术的进步进一步扩大了外泌体研究和临床应用的范围。

市场动态：

推动外泌体诊断和治疗市场发展的关键因素是对非侵入性诊断方法的需求不断增长、目标疾病的盛行率不断上升、基于外泌体的疗法相对于传统药物的优势以及技术进步。然而，分离技术和表征工具的高成本以及缺乏标准化限制了市场的成长。从积极的一面来看，改善的访问和持续的改进正在创造新的机会。抗衰老药物、不孕症治疗和感染疾病预防的新应用也前景看好。

本研究的主要特点

本报告对全球外泌体诊断和治疗市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。

它强调了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。

全球外泌体诊断和治疗市场的主要企业根据公司亮点、产品系列、关键亮点、绩效和策略等参数进行分析。

研究涉及的主要企业包括 Evox Therapeutics Ltd、Exosome Diagnostics、Aethlon Medical、NanoSomix Inc、Thermo Fisher Scientific、Malvern Panalytical 和 System Biosciences LLC。

本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。

全球外泌体诊断和治疗市场报告涉及该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

相关人员可以透过用于分析全球外泌体诊断和治疗市场的各种策略矩阵来促进他们的决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章市场动态、法规与趋势分析

• 市场动态
• 影响分析
• 主要亮点
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景

4. 全球外泌体诊断与治疗市场（按类型），2025-2032

• 外泌体诊断
• 外泌体治疗

5. 2025-2032 年全球外泌体诊断和治疗市场（按产品和服务划分）

• 设备和服务
• 套件和试剂

6. 全球外泌体诊断与治疗市场（依来源划分），2025 年至 2032 年

• 干细胞
• 血液和血浆
• 尿
• 其他来源

7. 全球外泌体诊断与治疗市场（按应用划分），2025 年至 2032 年

• 癌症
• 皮肤病
• 肌肉骨骼疾病
• 心血管疾病
• 其他的

8. 全球外泌体诊断与治疗市场（依最终使用者划分），2025 年至 2032 年

• 医院和诊断中心
• 诊所和医生环境
• 学术研究所
• 合约研究组织
• 其他的

9. 2020-2032 年全球外泌体诊断与治疗市场（按地区）

• 北美洲
• 美国
• 加拿大
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲
• 欧洲
• 德国
• 英国
• 西班牙
• 法国
• 义大利
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 中国
• 印度
• 日本
• 澳洲
• 韩国
• ASEAN
• 其他亚太地区
• 中东
• 海湾合作委员会国家
• 以色列
• 其他中东地区
• 非洲
• 南非
• 北非
• 中部非洲

第十章 竞争格局

• Thermo Fisher Scientific
• NanoSomix
• NX Pharmagen
• Malvern Instruments
• Capricor Therapeutic
• Exosome Diagnostics
• Exiqon A/S
• System Biosciences
• Exosome Sciences
• Aegle Therapeutic
• AMS Biotechnology
• Miltenyi Biotec
• Codiak BioSciences Inc.
• Lonza Group（HansaBioMed Life Sciences Ltd.）
• AcouSort AB
• Aethlon Medical, Inc.
• AGC Biologics
• Anjarium Biosciences AG
• Aruna Bio
• Brexogen
• Capricor Therapeutics
• Cells for Cells
• Ciloa
• ConvEyXO

第 11 章分析师建议

• 命运之轮
• 分析师观点
• 一致的机会图

第十二章参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Global Exosomes Diagnostic and Therapeutic Market is estimated to be valued at USD 92.8 Mn in 2025 and is expected to reach USD 308.4 Mn by 2032, growing at a compound annual growth rate (CAGR) of 18.7% from 2025 to 2032.

Figure. Exosomes Diagnostic And Therapeutic Market Share (%), By Region 2025

The global exosomes diagnostic and therapeutic market has been witnessing significant growth in the recent years. Exosomes are nano-sized extracellular vesicles that act as carriers of biomolecules like proteins, lipids, and nucleic acids. They play an important role in cell-to-cell communication and immune response. The growing application of exosomes in diagnosis and treatment of various diseases like cancer, neurological disorders, and cardiovascular conditions is driving the growth of this market. Researchers and healthcare industry players are increasingly leveraging the potential of exosomes for developing minimally invasive liquid biopsies, drug delivery solutions, and regenerative therapies. Advancements in isolation and characterization techniques are further expanding the scope of research as well as clinical use of exosomes.

Market Dynamics:

The key drivers propelling the exosomes diagnostic and therapeutic market include growing demand for non-invasive diagnostic methods, increasing prevalence of target diseases, advantages of exosome-based therapies over conventional drugs, and technological advancements. However, high costs associated with isolation techniques and characterization tools, as well as lack of standardization are limiting the market growth. On the positive side, improved access and ongoing refinements are creating new opportunities. Emerging applications in anti-aging therapeutics, fertility management, and infection control also hold promise.

Key features of the study:

This report provides in-depth analysis of the global exosomes diagnostic and therapeutic market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global exosomes diagnostic and therapeutic market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Evox Therapeutics Ltd, Exosome Diagnostics, Aethlon Medical, NanoSomix Inc, Thermo Fisher Scientific, Malvern Panalytical, System Biosciences LLC.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global exosomes diagnostic and therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global exosomes diagnostic and therapeutic market.

Detailed Segmentation:

• By Type Insights (Revenue, USD Mn, 2020 - 2032)
  • Exosome Diagnostics
  • Exosome Therapeutics
• By Product & Service Insights (Revenue, USD Mn, 2020 - 2032)
  • Instruments & Services
  • Kits & Reagents
• By Source Insights (Revenue, USD Mn, 2020 - 2032)
  • Stem Cells
  • Blood & Blood Plasma
  • Urine
  • Other Sources
• By Application Insights (Revenue, USD Mn, 2020 - 2032)
  • Cancer
  • Dermatological Diseases
  • Musculoskeletal Disorders
  • Cardiovascular Diseases
  • Others
• By End User Insights (Revenue, USD Mn, 2020 - 2032)
  • Hospitals & Diagnostic Centers
  • Clinics and Physician Settings
  • Academic and Research Institutions
  • Contract Research Organizations
  • Others
• By Regional Insights (Revenue, USD Mn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Thermo Fisher Scientific
  • NanoSomix
  • NX Pharmagen
  • Malvern Instruments
  • Capricor Therapeutic
  • Exosome Diagnostics
  • Exiqon A/S
  • System Biosciences
  • Exosome Sciences
  • Aegle Therapeutic
  • AMS Biotechnology
  • Miltenyi Biotec
  • Codiak BioSciences Inc.
  • Lonza Group (HansaBioMed Life Sciences Ltd.)
  • AcouSort AB
  • Aethlon Medical, Inc.
  • AGC Biologics
  • Anjarium Biosciences AG
  • Aruna Bio
  • Brexogen
  • Capricor Therapeutics
  • Cells for Cells
  • Ciloa
  • ConvEyXO

Table of Contents

1. RESEARCH OBJECTIVES AND ASSUMPTIONS

• Research Objectives
• Assumptions
• Abbreviations

2. MARKET PURVIEW

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Exosomes Diagnostic and Therapeutic Market, By Type
  • Global Exosomes Diagnostic and Therapeutic Market, By Product & Service
  • Global Exosomes Diagnostic and Therapeutic Market, By Source
  • Global Exosomes Diagnostic and Therapeutic Market, By Application
  • Global Exosomes Diagnostic and Therapeutic Market, By End User
  • Global Exosomes Diagnostic and Therapeutic Market, By Region

3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Exosomes Diagnostic and Therapeutic Market, By Type, 2025-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Exosome Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Exosome Therapeutics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Exosomes Diagnostic and Therapeutic Market, By Product & Service, 2025-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Instruments & Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Kits & Reagents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Exosomes Diagnostic and Therapeutic Market, By Source, 2025-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Stem Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Blood & Blood Plasma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Urine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Other Sources
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Exosomes Diagnostic and Therapeutic Market, By Application, 2025-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Dermatological Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Musculoskeletal Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Cardiovascular Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Exosomes Diagnostic and Therapeutic Market, By End User, 2025-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals & Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Clinics and Physician Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Academic and Research Institutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Contract Research Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Exosomes Diagnostic and Therapeutic Market, By Region, 2020 - 2032, Value (USD Mn)

• Introduction
  • Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Mn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2032, Value (USD Mn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
• South Africa
• North Africa
• Central Africa

10. COMPETITIVE LANDSCAPE

• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• NanoSomix
• NX Pharmagen
• Malvern Instruments
• Capricor Therapeutic
• Exosome Diagnostics
• Exiqon A/S
• System Biosciences
• Exosome Sciences
• Aegle Therapeutic
• AMS Biotechnology
• Miltenyi Biotec
• Codiak BioSciences Inc.
• Lonza Group (HansaBioMed Life Sciences Ltd.)
• AcouSort AB
• Aethlon Medical, Inc.
• AGC Biologics
• Anjarium Biosciences AG
• Aruna Bio
• Brexogen
• Capricor Therapeutics
• Cells for Cells
• Ciloa
• ConvEyXO

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us